UC Davis Professors David Segal, Kyle Fink, and Jill Silverman were awarded a $1.3 million grant from the California Institute for Regenerative Medicine (CIRM) to develop a molecular therapy for Angelman Syndrome using the Ube3a deletion rat model. Their application was ranked #1 in a list of over 100 applicants. The award was covered by several news outlets:
UC Davis Office of Research Announcement